Adawi Kamal
Insider CIK 1788393 · XGN Chief Financial Officer · FATE Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FATE FATE THERAPEUTICS INC | A Award deriv | 2026-01-15 | 2026-01-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2026-01-15 | 2026-01-16 | 25,000 | — | $0 | 100,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2025-10-20 | 2025-10-21 | 375,000 | — | $0 | 375,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2025-10-20 | 2025-10-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| XGN EXAGEN INC. | S Sale | 2024-03-04 | 2024-03-06 | 9,297 | $1.91 | $17.8K | 247,236 | SEC↗ |
| XGN EXAGEN INC. | S Sale | 2024-03-04 | 2024-03-06 | 3,487 | $1.91 | $6.7K | 243,749 | SEC↗ |
| XGN EXAGEN INC. | A Award | 2024-02-20 | 2024-02-22 | 75,000 | — | $0 | 256,533 | SEC↗ |
| XGN EXAGEN INC. | S Sale | 2024-02-06 | 2024-02-08 | 6,738 | $1.95 | $13.1K | 181,533 | SEC↗ |
| XGN EXAGEN INC. | S Sale | 2023-03-02 | 2023-03-03 | 3,667 | $2.30 | $8.4K | 188,271 | SEC↗ |
| XGN EXAGEN INC. | A Award | 2023-02-27 | 2023-03-01 | 100,000 | — | $0 | 191,938 | SEC↗ |
| XGN EXAGEN INC. | S Sale | 2023-02-08 | 2023-02-10 | 5,821 | $2.69 | $15.7K | 91,938 | SEC↗ |
| XGN EXAGEN INC. | F Tax w/h | 2022-03-01 | 2022-03-02 | 3,241 | $7.12 | $23.1K | 97,759 | SEC↗ |
| XGN EXAGEN INC. | A Award | 2022-02-04 | 2022-02-08 | 63,500 | — | $0 | 101,000 | SEC↗ |
| XGN EXAGEN INC. | A Award deriv | 2021-02-23 | 2021-02-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| XGN EXAGEN INC. | A Award | 2021-02-23 | 2021-02-25 | 37,500 | — | $0 | 37,500 | SEC↗ |
| XGN EXAGEN INC. | A Award deriv | 2020-01-09 | 2020-01-09 | 52,500 | — | $0 | 52,500 | SEC↗ |
| XGN EXAGEN INC. | A Award deriv | 2019-09-18 | 2019-09-20 | 21,635 | — | $0 | 21,635 | SEC↗ |